Artelo Biosciences Management
Management criteria checks 2/4
Artelo Biosciences' CEO is Greg Gorgas, appointed in Apr 2017, has a tenure of 7.17 years. total yearly compensation is $994.10K, comprised of 48.8% salary and 51.2% bonuses, including company stock and options. directly owns 0.63% of the company’s shares, worth $26.63K. The average tenure of the management team and the board of directors is 5.6 years and 5.6 years respectively.
Key information
Greg Gorgas
Chief executive officer
US$994.1k
Total compensation
| CEO salary percentage | 48.8% |
| CEO tenure | 7.2yrs |
| CEO ownership | 0.6% |
| Management average tenure | 5.6yrs |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
Artelo jumps 21% as publication highlights pre-clinical data on drug platform
Aug 16Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans
Mar 28
Artelo Biosciences Rounding A Corner With Cannabinoid-Based Therapy
Mar 09Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?
Nov 02Relief For Cancer Patients In Artelo Bioscience Pipeline
Jul 12Artelo Biosciences (NASDAQ:ARTL) Is In A Good Position To Deliver On Growth Plans
May 20Is Artelo Biosciences (NASDAQ:ARTL) In A Good Position To Invest In Growth?
Feb 04INO, VXRT, BTU and TTM among premarket gainers
Feb 02Artelo Biosciences EPS misses by $0.04
Jan 14Artelo Biosciences on go with cancer appetite recovery study
Nov 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | US$994k | US$485k | -US$9m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$9m |
| Mar 31 2023 | n/a | n/a | -US$10m |
| Dec 31 2022 | US$655k | US$440k | -US$10m |
| Sep 30 2022 | n/a | n/a | -US$13m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | -US$12m |
| Dec 31 2021 | US$1m | US$142k | -US$12m |
| Nov 30 2021 | n/a | n/a | -US$9m |
| Aug 31 2021 | n/a | n/a | -US$7m |
| May 31 2021 | n/a | n/a | -US$7m |
| Feb 28 2021 | n/a | n/a | -US$5m |
| Nov 30 2020 | n/a | n/a | -US$5m |
| Aug 31 2020 | US$581k | US$431k | -US$5m |
| May 31 2020 | n/a | n/a | -US$4m |
| Feb 29 2020 | n/a | n/a | -US$4m |
| Nov 30 2019 | n/a | n/a | -US$3m |
| Aug 31 2019 | US$347k | US$209k | -US$2m |
| May 31 2019 | n/a | n/a | -US$2m |
| Feb 28 2019 | n/a | n/a | -US$2m |
| Nov 30 2018 | n/a | n/a | -US$3m |
| Aug 31 2018 | US$75k | US$75k | -US$2m |
Compensation vs Market: Greg's total compensation ($USD994.10K) is above average for companies of similar size in the US market ($USD683.97K).
Compensation vs Earnings: Greg's compensation has increased whilst the company is unprofitable.
CEO
Greg Gorgas (61 yo)
7.2yrs
Tenure
US$994,095
Compensation
Mr. Gregory D. Gorgas, also known as Greg, M.B.A. has been the Chief Executive Officer, President, Chief Financial Officer, Secretary and Treasurer of Artelo Biosciences, Inc. since April 3, 2017. He has e...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.2yrs | US$994.10k | 0.63% $ 26.6k | |
| Senior VP & Chief Scientific Officer | 3.3yrs | no data | no data | |
| Chief Medical Officer | 6.2yrs | no data | no data | |
| Senior Vice President of Finance | 5.1yrs | no data | no data |
5.6yrs
Average Tenure
61yo
Average Age
Experienced Management: ARTL's management team is seasoned and experienced (5.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 7.2yrs | US$994.10k | 0.63% $ 26.6k | |
| Independent Chairperson of the Board | 7.1yrs | US$74.41k | 0.12% $ 4.9k | |
| Independent Director | 6.8yrs | US$41.91k | 0.026% $ 1.1k | |
| Independent Director | 3.3yrs | US$55.80k | 0% $ 0 | |
| Independent Director | 7.1yrs | US$57.41k | 0.026% $ 1.1k | |
| Member of the Advisory Board | 2.7yrs | no data | no data | |
| Independent Director | 3.6yrs | US$42.41k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.5yrs | no data | no data | |
| Independent Director | 6.9yrs | US$45.91k | 0.026% $ 1.1k | |
| Member of Scientific Advisor Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.5yrs | no data | no data |
5.6yrs
Average Tenure
69yo
Average Age
Experienced Board: ARTL's board of directors are considered experienced (5.6 years average tenure).